ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TCF12
|
ENSG00000140262.13 | TCF12 |
ASCL2
|
ENSG00000183734.4 | ASCL2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TCF12 | hg19_v2_chr15_+_57210961_57211030 | -0.18 | 4.9e-01 | Click! |
ASCL2 | hg19_v2_chr11_-_2292182_2292212 | 0.14 | 6.1e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_+_23847339 | 16.73 |
ENST00000303531.7 |
PRKCB |
protein kinase C, beta |
chr16_+_23847267 | 15.97 |
ENST00000321728.7 |
PRKCB |
protein kinase C, beta |
chr22_+_23241661 | 8.26 |
ENST00000390322.2 |
IGLJ2 |
immunoglobulin lambda joining 2 |
chr16_-_89043377 | 7.10 |
ENST00000436887.2 ENST00000448839.1 ENST00000360302.2 |
CBFA2T3 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
chr16_+_32077386 | 6.66 |
ENST00000354689.6 |
IGHV3OR16-9 |
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
chr17_+_76164639 | 6.18 |
ENST00000225777.3 ENST00000585591.1 ENST00000589711.1 ENST00000588282.1 ENST00000589168.1 |
SYNGR2 |
synaptogyrin 2 |
chr17_+_76165213 | 6.15 |
ENST00000590201.1 |
SYNGR2 |
synaptogyrin 2 |
chr15_+_89182178 | 5.96 |
ENST00000559876.1 |
ISG20 |
interferon stimulated exonuclease gene 20kDa |
chr20_+_37434329 | 5.81 |
ENST00000299824.1 ENST00000373331.2 |
PPP1R16B |
protein phosphatase 1, regulatory subunit 16B |
chr15_+_89181974 | 5.56 |
ENST00000306072.5 |
ISG20 |
interferon stimulated exonuclease gene 20kDa |
chr15_+_89182156 | 5.40 |
ENST00000379224.5 |
ISG20 |
interferon stimulated exonuclease gene 20kDa |
chr16_-_89043605 | 4.89 |
ENST00000268679.4 |
CBFA2T3 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
chr4_+_154387480 | 4.73 |
ENST00000409663.3 ENST00000440693.1 ENST00000409959.3 |
KIAA0922 |
KIAA0922 |
chr2_-_158345462 | 4.57 |
ENST00000439355.1 ENST00000540637.1 |
CYTIP |
cytohesin 1 interacting protein |
chr17_+_34538310 | 4.46 |
ENST00000444414.1 ENST00000378350.4 ENST00000389068.5 ENST00000588929.1 ENST00000589079.1 ENST00000589336.1 ENST00000400702.4 ENST00000591167.1 ENST00000586598.1 ENST00000591637.1 ENST00000378352.4 ENST00000358756.5 |
CCL4L1 |
chemokine (C-C motif) ligand 4-like 1 |
chr17_+_34431212 | 4.39 |
ENST00000394495.1 |
CCL4 |
chemokine (C-C motif) ligand 4 |
chr21_-_46330545 | 4.26 |
ENST00000320216.6 ENST00000397852.1 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr22_-_37882395 | 4.20 |
ENST00000416983.3 ENST00000424765.2 ENST00000356998.3 |
MFNG |
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
chr11_+_71249071 | 4.20 |
ENST00000398534.3 |
KRTAP5-8 |
keratin associated protein 5-8 |
chr14_-_106692191 | 4.13 |
ENST00000390607.2 |
IGHV3-21 |
immunoglobulin heavy variable 3-21 |
chr5_-_150603679 | 3.94 |
ENST00000355417.2 |
CCDC69 |
coiled-coil domain containing 69 |
chr14_+_31343747 | 3.90 |
ENST00000216361.4 ENST00000396618.3 ENST00000475087.1 |
COCH |
cochlin |
chr3_+_121554046 | 3.86 |
ENST00000273668.2 ENST00000451944.2 |
EAF2 |
ELL associated factor 2 |
chr11_+_7597639 | 3.70 |
ENST00000533792.1 |
PPFIBP2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
chr11_-_33891362 | 3.59 |
ENST00000395833.3 |
LMO2 |
LIM domain only 2 (rhombotin-like 1) |
chr11_+_128634589 | 3.55 |
ENST00000281428.8 |
FLI1 |
Fli-1 proto-oncogene, ETS transcription factor |
chr22_+_23247030 | 3.46 |
ENST00000390324.2 |
IGLJ3 |
immunoglobulin lambda joining 3 |
chr5_+_156693091 | 3.41 |
ENST00000318218.6 ENST00000442283.2 ENST00000522463.1 ENST00000521420.1 |
CYFIP2 |
cytoplasmic FMR1 interacting protein 2 |
chr1_-_9129598 | 3.40 |
ENST00000535586.1 |
SLC2A5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
chr15_+_74833518 | 3.39 |
ENST00000346246.5 |
ARID3B |
AT rich interactive domain 3B (BRIGHT-like) |
chr1_-_9129735 | 3.37 |
ENST00000377424.4 |
SLC2A5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
chr1_-_27961720 | 3.35 |
ENST00000545953.1 ENST00000374005.3 |
FGR |
feline Gardner-Rasheed sarcoma viral oncogene homolog |
chr17_+_34640031 | 3.33 |
ENST00000339270.6 ENST00000482104.1 |
CCL4L2 |
chemokine (C-C motif) ligand 4-like 2 |
chr2_-_152146385 | 3.33 |
ENST00000414946.1 ENST00000243346.5 |
NMI |
N-myc (and STAT) interactor |
chr5_-_94620239 | 3.32 |
ENST00000515393.1 |
MCTP1 |
multiple C2 domains, transmembrane 1 |
chr1_+_156119798 | 3.27 |
ENST00000355014.2 |
SEMA4A |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr14_-_106322288 | 3.23 |
ENST00000390559.2 |
IGHM |
immunoglobulin heavy constant mu |
chr1_+_111772314 | 3.15 |
ENST00000466741.1 ENST00000477185.2 |
CHI3L2 |
chitinase 3-like 2 |
chr17_+_34639793 | 3.09 |
ENST00000394465.2 ENST00000394463.2 ENST00000378342.4 |
CCL4L2 |
chemokine (C-C motif) ligand 4-like 2 |
chr1_-_154842741 | 3.09 |
ENST00000271915.4 |
KCNN3 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 |
chr1_-_9129631 | 3.01 |
ENST00000377414.3 |
SLC2A5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
chr22_+_24823517 | 2.98 |
ENST00000496258.1 ENST00000337539.7 |
ADORA2A |
adenosine A2a receptor |
chr6_-_32634425 | 2.89 |
ENST00000399082.3 ENST00000399079.3 ENST00000374943.4 ENST00000434651.2 |
HLA-DQB1 |
major histocompatibility complex, class II, DQ beta 1 |
chr2_+_33701286 | 2.87 |
ENST00000403687.3 |
RASGRP3 |
RAS guanyl releasing protein 3 (calcium and DAG-regulated) |
chr17_+_34430980 | 2.74 |
ENST00000250151.4 |
CCL4 |
chemokine (C-C motif) ligand 4 |
chr4_+_89378261 | 2.72 |
ENST00000264350.3 |
HERC5 |
HECT and RLD domain containing E3 ubiquitin protein ligase 5 |
chrX_-_118827333 | 2.70 |
ENST00000360156.7 ENST00000354228.4 ENST00000489216.1 ENST00000354416.3 ENST00000394610.1 ENST00000343984.5 |
SEPT6 |
septin 6 |
chrX_+_129305623 | 2.70 |
ENST00000257017.4 |
RAB33A |
RAB33A, member RAS oncogene family |
chr22_+_23264766 | 2.55 |
ENST00000390331.2 |
IGLC7 |
immunoglobulin lambda constant 7 |
chr11_+_60223225 | 2.52 |
ENST00000524807.1 ENST00000345732.4 |
MS4A1 |
membrane-spanning 4-domains, subfamily A, member 1 |
chr11_+_60223312 | 2.51 |
ENST00000532491.1 ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1 |
membrane-spanning 4-domains, subfamily A, member 1 |
chr4_+_40198527 | 2.50 |
ENST00000381799.5 |
RHOH |
ras homolog family member H |
chr14_-_106963409 | 2.47 |
ENST00000390621.2 |
IGHV1-45 |
immunoglobulin heavy variable 1-45 |
chr1_-_9129895 | 2.43 |
ENST00000473209.1 |
SLC2A5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
chr9_+_100263912 | 2.43 |
ENST00000259365.4 |
TMOD1 |
tropomodulin 1 |
chr14_-_106926724 | 2.40 |
ENST00000434710.1 |
IGHV3-43 |
immunoglobulin heavy variable 3-43 |
chr10_+_97515409 | 2.33 |
ENST00000371207.3 ENST00000543964.1 |
ENTPD1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
chr8_+_56014949 | 2.31 |
ENST00000327381.6 |
XKR4 |
XK, Kell blood group complex subunit-related family, member 4 |
chr2_+_170590321 | 2.30 |
ENST00000392647.2 |
KLHL23 |
kelch-like family member 23 |
chr12_+_6554021 | 2.30 |
ENST00000266557.3 |
CD27 |
CD27 molecule |
chr7_+_150065879 | 2.29 |
ENST00000397281.2 ENST00000444957.1 ENST00000466559.1 ENST00000489432.2 ENST00000475514.1 ENST00000482680.1 ENST00000488943.1 ENST00000518514.1 ENST00000478789.1 |
REPIN1 ZNF775 |
replication initiator 1 zinc finger protein 775 |
chr11_-_73694346 | 2.28 |
ENST00000310473.3 |
UCP2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
chr5_+_75699149 | 2.27 |
ENST00000379730.3 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
chr5_+_156693159 | 2.24 |
ENST00000347377.6 |
CYFIP2 |
cytoplasmic FMR1 interacting protein 2 |
chr10_+_12391481 | 2.22 |
ENST00000378847.3 |
CAMK1D |
calcium/calmodulin-dependent protein kinase ID |
chr5_+_75699040 | 2.17 |
ENST00000274364.6 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
chr1_-_38273840 | 2.15 |
ENST00000373044.2 |
YRDC |
yrdC N(6)-threonylcarbamoyltransferase domain containing |
chr14_-_106471723 | 2.12 |
ENST00000390595.2 |
IGHV1-3 |
immunoglobulin heavy variable 1-3 |
chr5_-_169816638 | 2.12 |
ENST00000521859.1 ENST00000274629.4 |
KCNMB1 |
potassium large conductance calcium-activated channel, subfamily M, beta member 1 |
chr16_+_12058961 | 2.12 |
ENST00000053243.1 |
TNFRSF17 |
tumor necrosis factor receptor superfamily, member 17 |
chr6_-_32731299 | 2.11 |
ENST00000435145.2 ENST00000437316.2 |
HLA-DQB2 |
major histocompatibility complex, class II, DQ beta 2 |
chr16_+_12059050 | 2.08 |
ENST00000396495.3 |
TNFRSF17 |
tumor necrosis factor receptor superfamily, member 17 |
chr22_+_23134974 | 2.08 |
ENST00000390314.2 |
IGLV2-11 |
immunoglobulin lambda variable 2-11 |
chr10_-_64576105 | 2.08 |
ENST00000242480.3 ENST00000411732.1 |
EGR2 |
early growth response 2 |
chr6_+_135502408 | 2.07 |
ENST00000341911.5 ENST00000442647.2 ENST00000316528.8 |
MYB |
v-myb avian myeloblastosis viral oncogene homolog |
chr1_-_169680745 | 2.03 |
ENST00000236147.4 |
SELL |
selectin L |
chr14_-_91884150 | 2.02 |
ENST00000553403.1 |
CCDC88C |
coiled-coil domain containing 88C |
chr8_-_81083341 | 2.02 |
ENST00000519303.2 |
TPD52 |
tumor protein D52 |
chr6_+_135502466 | 2.00 |
ENST00000367814.4 |
MYB |
v-myb avian myeloblastosis viral oncogene homolog |
chr17_-_39191107 | 1.99 |
ENST00000344363.5 |
KRTAP1-3 |
keratin associated protein 1-3 |
chr1_+_207627575 | 1.98 |
ENST00000367058.3 ENST00000367057.3 ENST00000367059.3 |
CR2 |
complement component (3d/Epstein Barr virus) receptor 2 |
chr19_+_10397621 | 1.97 |
ENST00000380770.3 |
ICAM4 |
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) |
chr2_+_79740118 | 1.96 |
ENST00000496558.1 ENST00000451966.1 |
CTNNA2 |
catenin (cadherin-associated protein), alpha 2 |
chr14_-_107219365 | 1.95 |
ENST00000424969.2 |
IGHV3-74 |
immunoglobulin heavy variable 3-74 |
chr1_+_28206150 | 1.95 |
ENST00000456990.1 |
THEMIS2 |
thymocyte selection associated family member 2 |
chr3_-_194991876 | 1.95 |
ENST00000310380.6 |
XXYLT1 |
xyloside xylosyltransferase 1 |
chr8_+_28174649 | 1.91 |
ENST00000301908.3 |
PNOC |
prepronociceptin |
chr22_+_18593446 | 1.91 |
ENST00000316027.6 |
TUBA8 |
tubulin, alpha 8 |
chr19_-_6670128 | 1.90 |
ENST00000245912.3 |
TNFSF14 |
tumor necrosis factor (ligand) superfamily, member 14 |
chr12_-_15103621 | 1.89 |
ENST00000536592.1 |
ARHGDIB |
Rho GDP dissociation inhibitor (GDI) beta |
chr14_+_31343951 | 1.88 |
ENST00000556908.1 ENST00000555881.1 ENST00000460581.2 |
COCH |
cochlin |
chr20_+_62367989 | 1.87 |
ENST00000309546.3 |
LIME1 |
Lck interacting transmembrane adaptor 1 |
chr6_+_24495067 | 1.85 |
ENST00000357578.3 ENST00000546278.1 ENST00000491546.1 |
ALDH5A1 |
aldehyde dehydrogenase 5 family, member A1 |
chr7_+_116593568 | 1.82 |
ENST00000446490.1 |
ST7 |
suppression of tumorigenicity 7 |
chr14_+_75988851 | 1.81 |
ENST00000555504.1 |
BATF |
basic leucine zipper transcription factor, ATF-like |
chr1_-_24194771 | 1.81 |
ENST00000374479.3 |
FUCA1 |
fucosidase, alpha-L- 1, tissue |
chr12_+_65174519 | 1.78 |
ENST00000229088.6 |
TBC1D30 |
TBC1 domain family, member 30 |
chr12_+_7055767 | 1.77 |
ENST00000447931.2 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
chr10_-_23003460 | 1.77 |
ENST00000376573.4 |
PIP4K2A |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
chr22_-_23922410 | 1.77 |
ENST00000249053.3 |
IGLL1 |
immunoglobulin lambda-like polypeptide 1 |
chr6_+_31540056 | 1.76 |
ENST00000418386.2 |
LTA |
lymphotoxin alpha |
chr12_+_7055631 | 1.76 |
ENST00000543115.1 ENST00000399448.1 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
chr6_-_24911195 | 1.74 |
ENST00000259698.4 |
FAM65B |
family with sequence similarity 65, member B |
chr1_+_207627697 | 1.74 |
ENST00000458541.2 |
CR2 |
complement component (3d/Epstein Barr virus) receptor 2 |
chr20_-_52210368 | 1.73 |
ENST00000371471.2 |
ZNF217 |
zinc finger protein 217 |
chr3_-_121553830 | 1.73 |
ENST00000498104.1 ENST00000460108.1 ENST00000349820.6 ENST00000462442.1 ENST00000310864.6 |
IQCB1 |
IQ motif containing B1 |
chr22_-_42342692 | 1.72 |
ENST00000404067.1 ENST00000402338.1 |
CENPM |
centromere protein M |
chr5_-_149792295 | 1.70 |
ENST00000518797.1 ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74 |
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr13_-_47012325 | 1.70 |
ENST00000409879.2 |
KIAA0226L |
KIAA0226-like |
chr14_-_106539557 | 1.67 |
ENST00000390599.2 |
IGHV1-8 |
immunoglobulin heavy variable 1-8 |
chr20_+_48884002 | 1.67 |
ENST00000425497.1 ENST00000445003.1 |
RP11-290F20.3 |
RP11-290F20.3 |
chr10_-_6019984 | 1.66 |
ENST00000525219.2 |
IL15RA |
interleukin 15 receptor, alpha |
chr16_+_12059091 | 1.65 |
ENST00000562385.1 |
TNFRSF17 |
tumor necrosis factor receptor superfamily, member 17 |
chr12_-_53601000 | 1.62 |
ENST00000338737.4 ENST00000549086.2 |
ITGB7 |
integrin, beta 7 |
chr16_-_31076332 | 1.62 |
ENST00000539836.3 ENST00000535577.1 ENST00000442862.2 |
ZNF668 |
zinc finger protein 668 |
chr22_+_37257015 | 1.61 |
ENST00000447071.1 ENST00000248899.6 ENST00000397147.4 |
NCF4 |
neutrophil cytosolic factor 4, 40kDa |
chr7_+_116593433 | 1.60 |
ENST00000323984.3 ENST00000393449.1 |
ST7 |
suppression of tumorigenicity 7 |
chr12_+_54892550 | 1.59 |
ENST00000545638.2 |
NCKAP1L |
NCK-associated protein 1-like |
chr8_+_6565854 | 1.58 |
ENST00000285518.6 |
AGPAT5 |
1-acylglycerol-3-phosphate O-acyltransferase 5 |
chr11_-_57194218 | 1.58 |
ENST00000529554.1 |
SLC43A3 |
solute carrier family 43, member 3 |
chr1_-_31230650 | 1.58 |
ENST00000294507.3 |
LAPTM5 |
lysosomal protein transmembrane 5 |
chr19_+_1071203 | 1.57 |
ENST00000543365.1 |
HMHA1 |
histocompatibility (minor) HA-1 |
chr4_-_40517984 | 1.56 |
ENST00000381795.6 |
RBM47 |
RNA binding motif protein 47 |
chr1_-_202129704 | 1.55 |
ENST00000476061.1 ENST00000544762.1 ENST00000467283.1 ENST00000464870.1 ENST00000435759.2 ENST00000486116.1 ENST00000543735.1 ENST00000308986.5 ENST00000477625.1 |
PTPN7 |
protein tyrosine phosphatase, non-receptor type 7 |
chr19_-_11689752 | 1.54 |
ENST00000592659.1 ENST00000592828.1 ENST00000218758.5 ENST00000412435.2 |
ACP5 |
acid phosphatase 5, tartrate resistant |
chr7_-_150675372 | 1.54 |
ENST00000262186.5 |
KCNH2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
chr11_-_57194948 | 1.54 |
ENST00000533235.1 ENST00000526621.1 ENST00000352187.1 |
SLC43A3 |
solute carrier family 43, member 3 |
chr1_-_92351769 | 1.53 |
ENST00000212355.4 |
TGFBR3 |
transforming growth factor, beta receptor III |
chr16_+_29690358 | 1.53 |
ENST00000395384.4 ENST00000562473.1 |
QPRT |
quinolinate phosphoribosyltransferase |
chr10_-_115613828 | 1.53 |
ENST00000361384.2 |
DCLRE1A |
DNA cross-link repair 1A |
chr7_+_50344289 | 1.52 |
ENST00000413698.1 ENST00000359197.5 ENST00000331340.3 ENST00000357364.4 ENST00000343574.5 ENST00000349824.4 ENST00000346667.4 ENST00000440768.2 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
chr10_-_6019552 | 1.52 |
ENST00000379977.3 ENST00000397251.3 ENST00000397248.2 |
IL15RA |
interleukin 15 receptor, alpha |
chr7_+_130794846 | 1.52 |
ENST00000421797.2 |
MKLN1 |
muskelin 1, intracellular mediator containing kelch motifs |
chr1_+_32716840 | 1.51 |
ENST00000336890.5 |
LCK |
lymphocyte-specific protein tyrosine kinase |
chr12_-_53601055 | 1.51 |
ENST00000552972.1 ENST00000422257.3 ENST00000267082.5 |
ITGB7 |
integrin, beta 7 |
chr6_+_35995552 | 1.50 |
ENST00000468133.1 |
MAPK14 |
mitogen-activated protein kinase 14 |
chr15_+_89787180 | 1.49 |
ENST00000300027.8 ENST00000310775.7 ENST00000567891.1 ENST00000564920.1 ENST00000565255.1 ENST00000567996.1 ENST00000451393.2 ENST00000563250.1 |
FANCI |
Fanconi anemia, complementation group I |
chr2_+_127413704 | 1.48 |
ENST00000409836.3 |
GYPC |
glycophorin C (Gerbich blood group) |
chr15_+_50474385 | 1.47 |
ENST00000267842.5 |
SLC27A2 |
solute carrier family 27 (fatty acid transporter), member 2 |
chr14_-_106668095 | 1.47 |
ENST00000390606.2 |
IGHV3-20 |
immunoglobulin heavy variable 3-20 |
chr4_+_15779901 | 1.47 |
ENST00000226279.3 |
CD38 |
CD38 molecule |
chr17_-_46507537 | 1.47 |
ENST00000336915.6 |
SKAP1 |
src kinase associated phosphoprotein 1 |
chr15_+_68346501 | 1.46 |
ENST00000249636.6 |
PIAS1 |
protein inhibitor of activated STAT, 1 |
chr7_-_20256965 | 1.43 |
ENST00000400331.5 ENST00000332878.4 |
MACC1 |
metastasis associated in colon cancer 1 |
chr14_+_72399114 | 1.43 |
ENST00000553525.1 ENST00000555571.1 |
RGS6 |
regulator of G-protein signaling 6 |
chr11_+_1718425 | 1.42 |
ENST00000382160.1 |
KRTAP5-6 |
keratin associated protein 5-6 |
chr19_+_18284477 | 1.42 |
ENST00000407280.3 |
IFI30 |
interferon, gamma-inducible protein 30 |
chr2_+_68592305 | 1.42 |
ENST00000234313.7 |
PLEK |
pleckstrin |
chr5_+_169064245 | 1.41 |
ENST00000256935.8 |
DOCK2 |
dedicator of cytokinesis 2 |
chr3_-_182833863 | 1.39 |
ENST00000492597.1 |
MCCC1 |
methylcrotonoyl-CoA carboxylase 1 (alpha) |
chr2_+_127413677 | 1.39 |
ENST00000356887.7 |
GYPC |
glycophorin C (Gerbich blood group) |
chr1_+_32716857 | 1.39 |
ENST00000482949.1 ENST00000495610.2 |
LCK |
lymphocyte-specific protein tyrosine kinase |
chr16_+_2867164 | 1.38 |
ENST00000455114.1 ENST00000450020.3 |
PRSS21 |
protease, serine, 21 (testisin) |
chr17_-_46507567 | 1.38 |
ENST00000584924.1 |
SKAP1 |
src kinase associated phosphoprotein 1 |
chr1_+_11751748 | 1.38 |
ENST00000294485.5 |
DRAXIN |
dorsal inhibitory axon guidance protein |
chr1_+_110210644 | 1.37 |
ENST00000369831.2 ENST00000442650.1 ENST00000369827.3 ENST00000460717.3 ENST00000241337.4 ENST00000467579.3 ENST00000414179.2 ENST00000369829.2 |
GSTM2 |
glutathione S-transferase mu 2 (muscle) |
chr8_-_80993010 | 1.37 |
ENST00000537855.1 ENST00000520527.1 ENST00000517427.1 ENST00000448733.2 ENST00000379097.3 |
TPD52 |
tumor protein D52 |
chr16_-_21289627 | 1.37 |
ENST00000396023.2 ENST00000415987.2 |
CRYM |
crystallin, mu |
chr19_+_10397648 | 1.36 |
ENST00000340992.4 ENST00000393717.2 |
ICAM4 |
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) |
chr10_-_103347883 | 1.36 |
ENST00000339310.3 ENST00000370158.3 ENST00000299206.4 ENST00000456836.2 ENST00000413344.1 ENST00000429502.1 ENST00000430045.1 ENST00000370172.1 ENST00000436284.2 ENST00000370162.3 |
POLL |
polymerase (DNA directed), lambda |
chr7_+_150065278 | 1.36 |
ENST00000519397.1 ENST00000479668.1 ENST00000540729.1 |
REPIN1 |
replication initiator 1 |
chr19_-_59023348 | 1.36 |
ENST00000601355.1 ENST00000263093.2 |
SLC27A5 |
solute carrier family 27 (fatty acid transporter), member 5 |
chr7_-_150652924 | 1.35 |
ENST00000330883.4 |
KCNH2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
chr9_-_35619539 | 1.34 |
ENST00000396757.1 |
CD72 |
CD72 molecule |
chr19_-_18366182 | 1.34 |
ENST00000355502.3 |
PDE4C |
phosphodiesterase 4C, cAMP-specific |
chr5_-_176936844 | 1.34 |
ENST00000510380.1 ENST00000510898.1 ENST00000357198.4 |
DOK3 |
docking protein 3 |
chr14_+_60716159 | 1.33 |
ENST00000325658.3 |
PPM1A |
protein phosphatase, Mg2+/Mn2+ dependent, 1A |
chr13_+_33590553 | 1.33 |
ENST00000380099.3 |
KL |
klotho |
chr2_+_58655461 | 1.32 |
ENST00000429095.1 ENST00000429664.1 ENST00000452840.1 |
AC007092.1 |
long intergenic non-protein coding RNA 1122 |
chrX_-_48776292 | 1.32 |
ENST00000376509.4 |
PIM2 |
pim-2 oncogene |
chr19_+_42381337 | 1.31 |
ENST00000597454.1 ENST00000444740.2 |
CD79A |
CD79a molecule, immunoglobulin-associated alpha |
chr3_+_167453493 | 1.30 |
ENST00000295777.5 ENST00000472747.2 |
SERPINI1 |
serpin peptidase inhibitor, clade I (neuroserpin), member 1 |
chr1_+_209941827 | 1.30 |
ENST00000367023.1 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
chr1_-_39339777 | 1.30 |
ENST00000397572.2 |
MYCBP |
MYC binding protein |
chr10_-_115614127 | 1.30 |
ENST00000369305.1 |
DCLRE1A |
DNA cross-link repair 1A |
chr9_+_140172200 | 1.29 |
ENST00000357503.2 |
TOR4A |
torsin family 4, member A |
chr16_+_83932684 | 1.29 |
ENST00000262430.4 |
MLYCD |
malonyl-CoA decarboxylase |
chr22_-_29107919 | 1.29 |
ENST00000434810.1 ENST00000456369.1 |
CHEK2 |
checkpoint kinase 2 |
chr10_-_22292613 | 1.28 |
ENST00000376980.3 |
DNAJC1 |
DnaJ (Hsp40) homolog, subfamily C, member 1 |
chr16_-_103572 | 1.27 |
ENST00000293860.5 |
POLR3K |
polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa |
chr1_+_12227035 | 1.27 |
ENST00000376259.3 ENST00000536782.1 |
TNFRSF1B |
tumor necrosis factor receptor superfamily, member 1B |
chr19_-_6591113 | 1.26 |
ENST00000423145.3 ENST00000245903.3 |
CD70 |
CD70 molecule |
chr9_-_136024721 | 1.25 |
ENST00000393160.3 |
RALGDS |
ral guanine nucleotide dissociation stimulator |
chr3_+_182511266 | 1.25 |
ENST00000323116.5 ENST00000493826.1 |
ATP11B |
ATPase, class VI, type 11B |
chr3_-_197024394 | 1.25 |
ENST00000434148.1 ENST00000412364.2 ENST00000436682.1 ENST00000456699.2 ENST00000392380.2 |
DLG1 |
discs, large homolog 1 (Drosophila) |
chr12_+_69202795 | 1.25 |
ENST00000539479.1 ENST00000393415.3 ENST00000523991.1 ENST00000543323.1 ENST00000393416.2 |
MDM2 |
MDM2 oncogene, E3 ubiquitin protein ligase |
chr3_-_125239010 | 1.25 |
ENST00000536067.1 ENST00000251775.4 |
SNX4 |
sorting nexin 4 |
chr13_+_33160553 | 1.24 |
ENST00000315596.10 |
PDS5B |
PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) |
chr11_+_117857063 | 1.23 |
ENST00000227752.3 ENST00000541785.1 ENST00000545409.1 |
IL10RA |
interleukin 10 receptor, alpha |
chr1_+_158801095 | 1.23 |
ENST00000368141.4 |
MNDA |
myeloid cell nuclear differentiation antigen |
chr6_-_31550192 | 1.21 |
ENST00000429299.2 ENST00000446745.2 |
LTB |
lymphotoxin beta (TNF superfamily, member 3) |
chr8_+_28196157 | 1.21 |
ENST00000522209.1 |
PNOC |
prepronociceptin |
chr2_-_160761179 | 1.21 |
ENST00000554112.1 ENST00000553424.1 ENST00000263636.4 ENST00000504764.1 ENST00000505052.1 |
LY75 LY75-CD302 |
lymphocyte antigen 75 LY75-CD302 readthrough |
chr5_-_138725594 | 1.21 |
ENST00000302125.8 |
MZB1 |
marginal zone B and B1 cell-specific protein |
chr12_+_124196865 | 1.20 |
ENST00000330342.3 |
ATP6V0A2 |
ATPase, H+ transporting, lysosomal V0 subunit a2 |
chr5_-_138725560 | 1.20 |
ENST00000412103.2 ENST00000457570.2 |
MZB1 |
marginal zone B and B1 cell-specific protein |
chr11_-_57194418 | 1.20 |
ENST00000395123.2 ENST00000530005.1 ENST00000532278.1 |
SLC43A3 |
solute carrier family 43, member 3 |
chr19_+_42381173 | 1.19 |
ENST00000221972.3 |
CD79A |
CD79a molecule, immunoglobulin-associated alpha |
chr5_+_43603229 | 1.19 |
ENST00000344920.4 ENST00000512996.2 |
NNT |
nicotinamide nucleotide transhydrogenase |
chr17_-_35969409 | 1.19 |
ENST00000394378.2 ENST00000585472.1 ENST00000591288.1 ENST00000502449.2 ENST00000345615.4 ENST00000346661.4 ENST00000585689.1 ENST00000339208.6 |
SYNRG |
synergin, gamma |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 34.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 1.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 2.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 3.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 0.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 3.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 10.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 7.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 9.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 0.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 2.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 0.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 8.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 13.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 5.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 4.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 3.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 7.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 3.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 3.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 2.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 2.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 3.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 1.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 4.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.7 | PID ATM PATHWAY | ATM pathway |
0.1 | 2.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 3.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.0 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.5 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 1.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 6.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 1.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 1.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 1.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 2.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 1.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 1.4 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.8 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 1.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 1.1 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 1.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 1.9 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 1.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 1.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.6 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 1.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 2.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 4.3 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.8 | 3.1 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.7 | 35.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.6 | 4.4 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.6 | 2.9 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.5 | 2.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 1.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.4 | 7.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.4 | 1.9 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.3 | 4.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 3.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 0.9 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.3 | 0.9 | GO:0031519 | PcG protein complex(GO:0031519) |
0.3 | 0.9 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.3 | 0.9 | GO:0030689 | Noc complex(GO:0030689) |
0.3 | 2.4 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 1.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 1.4 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.3 | 0.8 | GO:0036398 | TCR signalosome(GO:0036398) |
0.2 | 1.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 1.2 | GO:0098793 | presynapse(GO:0098793) |
0.2 | 1.5 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.2 | 16.8 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 2.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 1.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 5.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 0.9 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.2 | 1.2 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.2 | 0.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 0.9 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 4.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 2.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 0.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 1.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.5 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.2 | 0.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 1.1 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 1.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 1.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 0.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 1.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 0.5 | GO:0001652 | granular component(GO:0001652) |
0.2 | 0.2 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.1 | 0.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 1.0 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 2.0 | GO:0097227 | sperm annulus(GO:0097227) |
0.1 | 0.7 | GO:0097125 | condensed nuclear chromosome outer kinetochore(GO:0000942) cyclin B1-CDK1 complex(GO:0097125) |
0.1 | 0.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 1.2 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.4 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
0.1 | 0.4 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 1.0 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 1.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.5 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 2.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 1.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 2.0 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 10.7 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 1.4 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.5 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 1.0 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 1.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 12.5 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 1.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.5 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 4.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.3 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.1 | 0.8 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.4 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 8.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 4.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.9 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 4.2 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.3 | GO:0060187 | cell pole(GO:0060187) |
0.1 | 0.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.3 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 1.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.6 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.2 | GO:0032302 | MutSbeta complex(GO:0032302) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 0.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.3 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 1.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.5 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.1 | 2.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.7 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 1.0 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 1.2 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.6 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 2.7 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.8 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 1.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.4 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 2.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 0.4 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.1 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
0.1 | 1.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 2.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 1.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 1.7 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 1.4 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.2 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.1 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.4 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.1 | 1.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 1.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 2.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.1 | 1.0 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 2.1 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 3.5 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.0 | 1.0 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 3.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.1 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.7 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.3 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 1.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 2.5 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.0 | 0.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.7 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 2.3 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 1.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.4 | GO:0016013 | syntrophin complex(GO:0016013) |
0.0 | 2.4 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.8 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 2.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 1.4 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.0 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 1.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.2 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.0 | 0.1 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 1.2 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 0.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 3.5 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.0 | 0.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 2.2 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.5 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.9 | GO:0030684 | preribosome(GO:0030684) |
0.0 | 0.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.6 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 13.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 8.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 1.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 1.1 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.5 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 1.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.0 | 0.2 | GO:0044292 | dendrite terminus(GO:0044292) dendritic growth cone(GO:0044294) |
0.0 | 0.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 1.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.3 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 0.7 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.2 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.0 | 1.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.1 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.0 | 0.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.6 | GO:0071564 | npBAF complex(GO:0071564) nBAF complex(GO:0071565) |
0.0 | 0.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.7 | GO:0044455 | mitochondrial membrane part(GO:0044455) |
0.0 | 1.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.0 | 1.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.1 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.9 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.0 | GO:0097449 | astrocyte projection(GO:0097449) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.9 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.7 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.5 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 0.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.1 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.0 | 5.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.0 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 1.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 1.1 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.2 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 1.1 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 47.3 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.2 | GO:0005844 | polysome(GO:0005844) |
0.0 | 1.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) organelle inner membrane(GO:0019866) |
0.0 | 0.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 1.4 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.0 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.0 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.2 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.0 | GO:0002177 | manchette(GO:0002177) |
0.0 | 1.5 | GO:0019867 | outer membrane(GO:0019867) |
0.0 | 0.1 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.0 | 0.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 32.5 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.5 | 11.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 4.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.4 | 10.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 5.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 5.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 5.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 5.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 5.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 0.4 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 17.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 12.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 2.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 2.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 3.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 2.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 2.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 0.6 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 3.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 5.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 4.0 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 1.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 2.5 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.1 | 3.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 5.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.7 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 1.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.9 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 3.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 5.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 2.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 2.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.8 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 3.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 2.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 3.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 1.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.7 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 5.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 2.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 2.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 2.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 0.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 5.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 1.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 1.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 1.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 2.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 5.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.5 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 1.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 1.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 1.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.9 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 1.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 4.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 3.2 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.4 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 1.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 1.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 1.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.4 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 1.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 1.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.4 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.9 | 32.7 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
5.6 | 16.9 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
1.7 | 12.2 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
1.1 | 7.6 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.1 | 4.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.8 | 4.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.8 | 3.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.7 | 2.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.7 | 2.2 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.7 | 34.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.7 | 2.0 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
0.6 | 3.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.6 | 4.1 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.5 | 2.0 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) ethanolaminephosphotransferase activity(GO:0004307) |
0.5 | 4.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.5 | 3.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.5 | 1.5 | GO:0050135 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
0.5 | 2.9 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.5 | 2.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.5 | 1.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.5 | 1.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 2.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.4 | 4.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.4 | 6.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.4 | 2.2 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.4 | 1.7 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.4 | 1.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.4 | 1.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.4 | 0.4 | GO:0050436 | microfibril binding(GO:0050436) |
0.4 | 1.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.4 | 2.0 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.4 | 1.6 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.4 | 0.8 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.4 | 1.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.4 | 1.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 0.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 1.4 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.4 | 4.0 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
0.4 | 2.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.3 | 1.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 1.4 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.3 | 3.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.3 | 2.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 1.3 | GO:0008422 | beta-glucuronidase activity(GO:0004566) beta-glucosidase activity(GO:0008422) |
0.3 | 2.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.3 | 1.0 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.3 | 0.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 0.9 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.3 | 1.6 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.3 | 0.9 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.3 | 1.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 1.2 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.3 | 1.2 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.3 | 2.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 0.9 | GO:0002134 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.3 | 1.4 | GO:0070905 | serine binding(GO:0070905) |
0.3 | 4.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.3 | 4.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 1.1 | GO:0004335 | galactokinase activity(GO:0004335) |
0.3 | 1.4 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.3 | 0.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.3 | 1.1 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 0.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 1.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.3 | 0.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 0.8 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 0.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.2 | 1.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 1.0 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
0.2 | 0.7 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.2 | 5.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 1.2 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.2 | 2.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 1.4 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.2 | 0.7 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.2 | 3.2 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 3.7 | GO:0043295 | glutathione binding(GO:0043295) |
0.2 | 1.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.2 | 0.7 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
0.2 | 0.2 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.2 | 3.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 3.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 1.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 0.8 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 0.6 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.2 | 0.6 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.2 | 1.0 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.2 | 1.7 | GO:0015926 | glucosidase activity(GO:0015926) |
0.2 | 1.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 0.7 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.2 | 0.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 1.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 1.1 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.2 | 4.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 1.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 0.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 1.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 0.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 1.1 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.2 | 1.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 0.5 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.2 | 0.5 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.2 | 2.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 0.7 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.2 | 2.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.2 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 0.5 | GO:0000035 | acyl binding(GO:0000035) phosphopantetheine binding(GO:0031177) |
0.2 | 0.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 1.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 0.5 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
0.2 | 0.5 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.2 | 1.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 3.0 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 1.0 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 3.9 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.4 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.1 | 0.4 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.1 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.4 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 1.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 3.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 2.7 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.4 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.1 | 0.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.5 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.4 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.1 | 0.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 1.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 1.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.5 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 2.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 2.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 3.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 5.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 1.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.6 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.1 | 0.4 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.1 | 0.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.4 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 1.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.3 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.1 | 0.3 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 0.4 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.6 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.1 | 1.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 1.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 3.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 1.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.7 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.1 | 0.3 | GO:0017129 | triglyceride binding(GO:0017129) |
0.1 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.5 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.5 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.1 | 0.1 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.4 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.1 | 0.3 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 0.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 1.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.7 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 1.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.6 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.1 | 0.7 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 3.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 14.7 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.5 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.1 | 0.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 1.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 1.0 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.3 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 0.9 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.4 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 1.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.3 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.3 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 2.6 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 2.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 1.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.4 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.1 | 0.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 4.1 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.2 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.1 | 0.6 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.1 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.4 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 1.0 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.1 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.3 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 1.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 2.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 1.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 1.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 1.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.3 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.1 | 1.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.2 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.1 | 0.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 1.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 3.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 1.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.5 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 1.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 1.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.3 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.1 | 1.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.2 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.1 | 0.2 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 2.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 1.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 1.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 1.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.2 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 1.4 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 0.5 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.6 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.2 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.1 | 1.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 15.7 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.1 | GO:0004040 | amidase activity(GO:0004040) |
0.1 | 0.2 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.4 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.1 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 5.3 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.2 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.1 | 0.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.4 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.1 | 0.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.2 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.1 | 0.5 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.2 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.0 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 1.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.0 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.0 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.8 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.6 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.4 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.0 | 0.9 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.0 | 1.3 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.2 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.0 | 0.7 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.6 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.0 | 0.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.2 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.3 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.9 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.8 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.3 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.0 | 0.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.5 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 3.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 1.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.7 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 1.2 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.0 | 0.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.4 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.7 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 1.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.2 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.6 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.8 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.1 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.0 | 0.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 3.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 1.7 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.2 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.2 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.6 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.1 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 18.2 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) |
0.0 | 0.6 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.4 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.2 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.4 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 1.7 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.1 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.0 | 2.6 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 1.0 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 1.7 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 2.2 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.8 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.1 | GO:0034594 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.0 | 0.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.5 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 5.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.0 | 1.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.0 | 0.1 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.1 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.5 | GO:0016741 | transferase activity, transferring one-carbon groups(GO:0016741) |
0.0 | 2.7 | GO:0001067 | regulatory region DNA binding(GO:0000975) regulatory region nucleic acid binding(GO:0001067) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.6 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0045125 | sphingosine-1-phosphate receptor activity(GO:0038036) bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.4 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) poly(U) RNA binding(GO:0008266) |
0.0 | 0.4 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.9 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.3 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.0 | 0.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.1 | GO:1901567 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.0 | 0.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.3 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.0 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.0 | 0.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.9 | 32.7 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
5.6 | 16.9 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.9 | 5.8 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
1.7 | 12.2 | GO:1990539 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
1.7 | 5.1 | GO:1990922 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
1.5 | 12.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.4 | 2.9 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
1.2 | 3.7 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
1.1 | 7.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
1.0 | 3.0 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.9 | 3.5 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.9 | 1.8 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.9 | 2.6 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.8 | 4.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.8 | 3.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.8 | 3.1 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.8 | 3.1 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.7 | 3.7 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.7 | 2.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.7 | 5.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.7 | 2.1 | GO:1903413 | cellular response to bile acid(GO:1903413) |
0.7 | 2.0 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
0.6 | 0.6 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.6 | 3.5 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.5 | 0.5 | GO:1902961 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.5 | 1.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.5 | 1.5 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.5 | 1.4 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.5 | 33.6 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.5 | 1.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.4 | 2.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.4 | 1.8 | GO:0001757 | somite specification(GO:0001757) |
0.4 | 2.2 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.4 | 0.9 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.4 | 2.2 | GO:1901907 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.4 | 1.3 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.4 | 3.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 1.3 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.4 | 1.2 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
0.4 | 1.2 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.4 | 2.0 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.4 | 3.2 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.4 | 3.6 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.4 | 1.2 | GO:0072229 | proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
0.4 | 2.3 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.4 | 2.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.4 | 1.5 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.4 | 1.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.4 | 1.1 | GO:0070997 | neuron death(GO:0070997) |
0.4 | 1.9 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.4 | 1.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.4 | 1.1 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.4 | 4.0 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.4 | 2.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.4 | 1.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.4 | 4.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.3 | 1.4 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.3 | 1.7 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.3 | 2.3 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.3 | 0.7 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.3 | 1.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 1.0 | GO:0032759 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
0.3 | 2.6 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.3 | 1.3 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.3 | 1.3 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.3 | 0.9 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.3 | 1.6 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.3 | 0.9 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
0.3 | 0.9 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
0.3 | 0.9 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.3 | 0.9 | GO:0042495 | detection of bacterial lipoprotein(GO:0042494) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
0.3 | 1.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.3 | 0.9 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.3 | 1.5 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.3 | 0.9 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.9 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.3 | 5.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 0.3 | GO:1902995 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
0.3 | 1.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.3 | 0.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.3 | 1.4 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.3 | 0.3 | GO:1902003 | regulation of beta-amyloid formation(GO:1902003) |
0.3 | 0.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.3 | 0.3 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
0.3 | 0.8 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.3 | 1.3 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
0.3 | 2.8 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.3 | 0.8 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.3 | 1.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 1.5 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 5.6 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.3 | 2.5 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.2 | 1.0 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.2 | 1.0 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.2 | 1.5 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.2 | 3.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 1.2 | GO:0015862 | uridine transport(GO:0015862) |
0.2 | 0.2 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
0.2 | 0.7 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
0.2 | 0.7 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 1.4 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.2 | 0.7 | GO:1904647 | response to rotenone(GO:1904647) |
0.2 | 1.4 | GO:0015811 | L-cystine transport(GO:0015811) |
0.2 | 0.9 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 0.2 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
0.2 | 2.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 1.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.5 | GO:0007051 | spindle organization(GO:0007051) |
0.2 | 3.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 1.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 3.5 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.2 | 0.7 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.2 | 1.7 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.2 | 1.9 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 0.6 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.2 | 0.6 | GO:0035623 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
0.2 | 1.0 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.2 | 0.4 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.2 | 0.6 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.2 | 1.0 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.2 | 3.3 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.2 | 1.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 0.6 | GO:0006404 | RNA import into nucleus(GO:0006404) |
0.2 | 1.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 3.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 0.6 | GO:1902809 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.2 | 0.6 | GO:0035377 | transepithelial water transport(GO:0035377) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.2 | 3.8 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 1.2 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.2 | 0.2 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.2 | 0.2 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 0.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 1.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 0.8 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 0.4 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.2 | 0.6 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
0.2 | 0.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.2 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) |
0.2 | 0.7 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.2 | 0.2 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 1.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 2.7 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.2 | 0.5 | GO:2000611 | regulation of thyroid hormone generation(GO:2000609) positive regulation of thyroid hormone generation(GO:2000611) |
0.2 | 0.9 | GO:0072069 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
0.2 | 0.5 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 2.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 1.4 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 1.6 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.2 | 0.5 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.2 | 0.5 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 0.5 | GO:0072179 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm development(GO:0048389) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) pattern specification involved in mesonephros development(GO:0061227) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in kidney development(GO:0072098) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) nephric duct formation(GO:0072179) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
0.2 | 0.7 | GO:2000314 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.2 | 0.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 0.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 3.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 1.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.2 | 0.2 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.2 | 1.3 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.2 | 0.3 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.2 | 0.5 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.2 | 5.2 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.2 | 0.5 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.2 | 1.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.6 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
0.2 | 0.3 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.2 | 0.8 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) positive regulation of neutrophil apoptotic process(GO:0033031) |
0.2 | 2.0 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.8 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.2 | 1.4 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.2 | 2.9 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.2 | 0.6 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 0.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.2 | 2.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 0.8 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.2 | 0.3 | GO:0061010 | gall bladder development(GO:0061010) |
0.2 | 0.5 | GO:0048850 | hypophysis morphogenesis(GO:0048850) diencephalon morphogenesis(GO:0048852) |
0.1 | 3.0 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.9 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.1 | 0.6 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 0.1 | GO:0060775 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.1 | 0.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 2.3 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.1 | 0.4 | GO:0050894 | determination of affect(GO:0050894) |
0.1 | 0.7 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.6 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.1 | 0.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.4 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
0.1 | 0.4 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.1 | 0.6 | GO:1901723 | visceral serous pericardium development(GO:0061032) negative regulation of glomerular mesangial cell proliferation(GO:0072125) posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) negative regulation of glomerulus development(GO:0090194) negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.1 | 0.6 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.1 | 8.7 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 1.3 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.6 | GO:0003335 | corneocyte development(GO:0003335) |
0.1 | 0.4 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.1 | 0.4 | GO:0071790 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.1 | 0.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 1.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.5 | GO:0071362 | cellular response to ether(GO:0071362) |
0.1 | 0.4 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 0.8 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.1 | 0.3 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 0.8 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.1 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 6.8 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 0.3 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.1 | 0.5 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.1 | 0.4 | GO:0008050 | female courtship behavior(GO:0008050) |
0.1 | 0.5 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.5 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.5 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.1 | 2.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.3 | GO:0019751 | polyol metabolic process(GO:0019751) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.4 | GO:2000307 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) tumor necrosis factor (ligand) superfamily member 11 production(GO:0072535) positive regulation of bone mineralization involved in bone maturation(GO:1900159) regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000307) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
0.1 | 0.1 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.1 | 0.5 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.4 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.1 | 1.0 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.1 | 0.4 | GO:0001207 | histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.1 | 0.5 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.1 | 0.6 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 3.7 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 1.4 | GO:0006228 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.1 | 1.4 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.2 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.3 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.1 | 0.8 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 0.5 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.1 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.3 | GO:0032900 | negative regulation of neurotrophin production(GO:0032900) negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.2 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.1 | 0.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.2 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.4 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.1 | 0.8 | GO:0071315 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
0.1 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.3 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.7 | GO:0035799 | ureter maturation(GO:0035799) |
0.1 | 0.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.4 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.1 | 0.8 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.4 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.1 | 0.6 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.4 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
0.1 | 0.7 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 10.9 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.1 | 1.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.8 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 1.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 1.1 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.1 | 0.3 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
0.1 | 0.1 | GO:0032425 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
0.1 | 0.6 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.1 | 0.2 | GO:1901523 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.1 | 0.7 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 1.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.1 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.7 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 1.0 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 0.4 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.1 | 0.6 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 1.0 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.5 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.1 | 0.4 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.1 | 0.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.2 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.1 | 0.3 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.1 | 2.2 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.4 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.1 | 1.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.7 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.4 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 6.2 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 1.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.4 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 0.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.6 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 1.2 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.1 | 0.4 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.1 | 0.6 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 2.0 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.4 | GO:0051754 | meiotic sister chromatid cohesion(GO:0051177) meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.1 | 1.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.4 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.6 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 1.2 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.1 | 0.2 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.1 | 0.9 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.3 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.1 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.7 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
0.1 | 0.3 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.1 | 0.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.3 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 0.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.9 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.2 | GO:0006311 | meiotic gene conversion(GO:0006311) |
0.1 | 0.2 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.1 | 0.3 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.1 | 0.3 | GO:0072658 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.1 | 0.5 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.1 | 0.2 | GO:2000824 | proximal tubule development(GO:0072014) negative regulation of androgen receptor activity(GO:2000824) |
0.1 | 2.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.3 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.1 | 0.3 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.1 | 0.2 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.8 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.2 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 2.0 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.4 | GO:0055129 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
0.1 | 0.3 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 0.3 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.4 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.1 | 0.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.4 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 2.4 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 1.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.4 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 1.2 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 1.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.1 | GO:1903061 | regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
0.1 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 1.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 1.1 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.1 | 0.5 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.6 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.1 | 0.8 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.1 | 5.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 1.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 2.6 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.2 | GO:0070105 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.1 | 3.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 0.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 1.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.5 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.3 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.1 | 0.3 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 1.4 | GO:0050779 | RNA destabilization(GO:0050779) |
0.1 | 1.6 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.1 | 1.2 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.5 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 0.3 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.1 | 0.6 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.9 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 0.3 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 0.3 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.1 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.1 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) arterial endothelial cell differentiation(GO:0060842) |
0.1 | 0.1 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.1 | 2.0 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.6 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.2 | GO:1904383 | response to sodium phosphate(GO:1904383) response to insulin-like growth factor stimulus(GO:1990418) |
0.1 | 0.9 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.2 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.3 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 0.2 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 1.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 1.4 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.1 | 0.4 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.8 | GO:0070977 | bone maturation(GO:0070977) |
0.1 | 0.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 2.6 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.1 | 0.8 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 1.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 1.2 | GO:0050854 | regulation of antigen receptor-mediated signaling pathway(GO:0050854) |
0.1 | 0.2 | GO:0043456 | regulation of secondary metabolic process(GO:0043455) regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 1.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.1 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.1 | 1.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 3.3 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 0.1 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.1 | 0.2 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.4 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 1.7 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.6 | GO:0001502 | cartilage condensation(GO:0001502) |
0.1 | 0.3 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.1 | 0.8 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.2 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.1 | 0.5 | GO:0051973 | regulation of telomerase activity(GO:0051972) positive regulation of telomerase activity(GO:0051973) |
0.1 | 0.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.6 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.3 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.1 | 0.3 | GO:0002084 | protein depalmitoylation(GO:0002084) regulation of Golgi to plasma membrane protein transport(GO:0042996) negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.2 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) disaccharide biosynthetic process(GO:0046351) |
0.1 | 0.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.1 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.1 | 1.7 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.3 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.1 | 1.4 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 0.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 2.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.4 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.1 | 0.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.2 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 2.0 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.9 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.5 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.0 | 0.0 | GO:1904882 | establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.0 | 0.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.0 | 0.2 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.0 | 0.1 | GO:0036414 | protein citrullination(GO:0018101) citrulline biosynthetic process(GO:0019240) histone citrullination(GO:0036414) |
0.0 | 0.6 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 1.3 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
0.0 | 0.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.0 | 0.4 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.0 | 0.1 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.0 | 0.4 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.3 | GO:0060872 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
0.0 | 0.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.0 | 0.8 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.7 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.1 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.0 | 0.4 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 1.5 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.2 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.3 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.1 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.0 | 0.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0061436 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
0.0 | 0.1 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 1.9 | GO:0002223 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.0 | 0.4 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.3 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.0 | 0.3 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.0 | 0.1 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.0 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.2 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.0 | 0.2 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 2.2 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
0.0 | 0.1 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.0 | 0.2 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.1 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.0 | 0.2 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.0 | 0.4 | GO:0021915 | neural tube development(GO:0021915) |
0.0 | 0.5 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.0 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.4 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.3 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 1.5 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.9 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.0 | 0.6 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 1.1 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.7 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.0 | 0.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.3 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.4 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 3.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.6 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.2 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.0 | 1.0 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.3 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.0 | 1.0 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.0 | 0.1 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.1 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.0 | 0.3 | GO:0050864 | regulation of B cell activation(GO:0050864) |
0.0 | 0.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.8 | GO:1902749 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.0 | 0.1 | GO:0070541 | response to platinum ion(GO:0070541) |
0.0 | 1.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.4 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.1 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.0 | 0.3 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.2 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.0 | 1.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.0 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.0 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 1.1 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.7 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.4 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.0 | 0.7 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.2 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 0.2 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.0 | 0.6 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.3 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 1.3 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 2.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.1 | GO:1904833 | positive regulation of superoxide dismutase activity(GO:1901671) negative regulation of DNA catabolic process(GO:1903625) positive regulation of removal of superoxide radicals(GO:1904833) |
0.0 | 0.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.7 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.3 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.0 | 0.2 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.3 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.1 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) mesonephric duct morphogenesis(GO:0072180) |
0.0 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.2 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.0 | 0.5 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
0.0 | 0.3 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 4.2 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.0 | 0.1 | GO:0042426 | choline catabolic process(GO:0042426) |
0.0 | 0.1 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.0 | 0.4 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 1.1 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) negative regulation of leukocyte proliferation(GO:0070664) |
0.0 | 0.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.2 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.2 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.3 | GO:0021756 | striatum development(GO:0021756) |
0.0 | 0.2 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.5 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 1.0 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.7 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.6 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.4 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.1 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.0 | 0.9 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 0.7 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.8 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.3 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 1.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.7 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.1 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.3 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.0 | 0.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.4 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.1 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.0 | 0.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.0 | 0.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.2 | GO:1902358 | sulfate transmembrane transport(GO:1902358) |
0.0 | 0.1 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.0 | 0.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.1 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.4 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.1 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.5 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.0 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.3 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.0 | 0.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.1 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.2 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.0 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.6 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.0 | 0.4 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.0 | 0.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.2 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.0 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.1 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.0 | 0.1 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.0 | 0.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.2 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.2 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.0 | 0.3 | GO:0042593 | carbohydrate homeostasis(GO:0033500) glucose homeostasis(GO:0042593) |
0.0 | 0.3 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.0 | 0.2 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.3 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.0 | 0.1 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.0 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.1 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.0 | 1.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.2 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 1.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.0 | 0.1 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.5 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.1 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 0.3 | GO:0008344 | adult locomotory behavior(GO:0008344) |
0.0 | 0.1 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.0 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.4 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.1 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.1 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.0 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) |
0.0 | 0.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.0 | 0.2 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 0.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.0 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.0 | 0.0 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |